timothy sykes logo
Tempus AI Falls 10% as Market Selloff Hits AI Stocks Thumbnail

Tempus AI Falls 10% as Market Selloff Hits AI Stocks

TIMOTHY SYKES•UPDATED NOV. 20, 2026, 10:25 AM ET

Tempus AI fell 10% as a broad market selloff pulled shares lower.

TEM Candlestick Chart

Why Tempus AI Stock Is Falling Today

Today, a broad market selloff pulled Tempus AI Inc. down 10% to $53.78 during regular trading hours. Shares tied to artificial intelligence, software that finds patterns in data, also faced selling across the market.

Tempus AI Exposure to Growth Selling

The Nasdaq Composite, a measure of prices for stocks listed on the Nasdaq exchange, also dropped sharply as AI shares sold off. That decline provides context for Tempus’s move beyond its own business news. Tempus sells AI-based services, giving it exposure to shifts in interest in that technology.

Tempus AI and Future Earnings

Investors demanding a greater reward for risk pay less today for earnings expected later. Tempus’s current losses add context to its steeper decline, but do not establish how much of the gap they explain. The selling does not establish weaker testing demand or lost contracts.

Quick Financial Overview

Tempus has real sales but remains unprofitable, with $9.81B in stock-market value making it a mid-cap, meaning a medium-sized public company. It held $637.4M in cash, cash equivalents, and short-term investments as of September 30, 2026. That includes money on hand and investments that can be turned into cash.

What Tempus AI Inc. Does

Tempus sells tests that examine biological material for markers that can guide treatment. It combines patient information with artificial intelligence to help doctors choose care and drugmakers conduct research.

Tempus AI Revenue and Earnings

Quarterly revenue was $411.5M, alongside a net loss of $14.9M, meaning expenses exceeded revenue. Its day-to-day business activities generated cash during the quarter, so the accounting loss was not the same as cash leaving the business.

Tempus AI Securities Sale Document

Tempus filed a prospectus last month, a document describing investments such as shares or bonds that may be sold. Its existence alone does not establish that new shares were issued or that existing owners’ percentage stakes shrank.

Tempus AI Stock Retreats From Its Advance

Tempus remains up 16% from the $45 level six months ago. The retreat from the $70 level over the latest week is eroding that advance. For Tempus, the last daily move this large was nine sessions ago.

Trading Perspective

The stock is below the $60 level, making that a recovery reference rather than a level currently stopping declines. Farther above sits the $90 level, its annual-high reference. Recovering the nearer level would not prove the retreat has ended.


Tempus AI AstraZeneca Agreement Extension

The decline comes after drugmaker AstraZeneca extended its services agreement with Tempus. That preserves a longer customer relationship, although the extension alone does not show when revenue will be recorded.

Conclusion

The next consumer spending inflation report offers a macro checkpoint for Tempus. Softer inflation could support expectations for lower interest rates, making future earnings worth more today. Hotter inflation could keep pressure on its growth-based value, while an expected reading would offer less reason to reassess it.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”